SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan B. Brockman who wrote (234)2/13/1998 12:58:00 PM
From: Manny Gugliuzza  Read Replies (1) of 1510
 
but this is what remune was originally produced to do. although this does not hasten its approval buy the FDA with the triple combo drugs.

the ultimate test for remune is to inject healthy individuals and then challenge them with the virus. good luck getting FDA to ok this.

it does demonstrate remunes ability to work alone instead of with what i feel are drugs that actually hurt the bodies defenses bring on a more acute terminal aids from their failure.

and it will be useful as a comparative study and hopefully will show better immune resistance than with the combo drugs, even though they were not part of this study.

ar.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News